PHARMACOKINETICS AND SAFETY OF CT-P47, A PROPOSED TOCILIZUMAB BIOSIMILAR, IN COMPARISON WITH EU-APPROVED TOCILIZUMAB; A PHASE 1, RANDOMIZED, DOUBLE-BLIND, TWO-ARM, SINGLE-DOSE STUDY IN HEALTHY SUBJECTS

K. S. Yu, B. Kim,D. Shin, M. K. Park, J. G. Hwang, M. Kim, H. Chung,J. Ghim,J. Y. Chung,J. S. Smolen,G. R. Burmester, S. H. Kim,Y. Bae, D. Jeon, G. Yang, J. Yoo,J. Bae,E. Keystone

ANNALS OF THE RHEUMATIC DISEASES（2023）

Cited 0|Views0

Key words

Rheumatoid arthritis,Clinical Trials,bDMARD

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined